Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,643 | -20,759 | -46,229 | -31,456 | -30,347 |
| Depreciation Amortization | 163 | 78 | 297 | 219 | 141 |
| Accounts receivable | -526 | -775 | -483 | -451 | -129 |
| Accounts payable and accrued liabilities | 122 | 111 | -259 | 717 | 1,132 |
| Other Working Capital | 1,715 | 344 | -6,068 | -4,161 | -2,371 |
| Other Operating Activity | 7,971 | 14,783 | 14,921 | 7,039 | 12,476 |
| Operating Cash Flow | $-10,198 | $-6,218 | $-37,821 | $-28,093 | $-19,098 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -210 | -12 | -973 | -386 | -381 |
| Investing Cash Flow | $-210 | $-12 | $-973 | $-386 | $-381 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,000 | N/A | 5,000 | 5,000 | 5,000 |
| Debt Repayment | -4,866 | -419 | -3,180 | -3,039 | -3,074 |
| Common Stock Issued | 37,877 | 37,787 | 125 | 92 | 92 |
| Other Financing Activity | -3,280 | -2,389 | -291 | -292 | -223 |
| Financing Cash Flow | $39,731 | $34,979 | $1,654 | $1,761 | $1,795 |
| Exchange Rate Effect | 35 | -51 | 204 | 258 | 45 |
| Beginning Cash Position | 12,628 | 12,628 | 49,564 | 49,564 | 49,564 |
| End Cash Position | 41,986 | 41,326 | 12,628 | 23,104 | 31,925 |
| Net Cash Flow | $29,358 | $28,698 | $-36,936 | $-26,460 | $-17,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,198 | -6,218 | -37,821 | -28,093 | -19,098 |
| Capital Expenditure | -210 | -12 | -973 | -386 | -381 |
| Free Cash Flow | -10,408 | -6,230 | -38,794 | -28,479 | -19,479 |